Latest News about iNGENÅ«
Recent news which mentions iNGENÅ«
Psychedelic Research Expands In Australia With Palliative Care Partnership & New MDMA Analog Portfolio
March 21, 2023
From Benzinga
Novel Ketamine Topical Cream To Treat PTSD Gets First In-Human Trials
February 16, 2023
Tickers
BWVI
From Benzinga
Psychedelics Funding At Its Best: $1.5 M Destined To Psilocybin Clinical Trials In Australia
September 01, 2022
From Benzinga
This Psychedelic Company Just Signed An Exclusive Deal For Psilocin Clinical Trials In Australia
August 10, 2022
Tickers
LOBEF
From Benzinga